Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis

被引:0
|
作者
Fernandes Felix, Joao Paulo
Cavalcanti Lira, Rodrigo Pessoa
Grupenmacher, Alex Treiger
Gomes de Assis Filho, Hermano Lucio
Cosimo, Alexandre Brito
Nascimento, Mauricio Abujamra
Leite Arieta, Carlos Eduardo
机构
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:217 / 218
页数:3
相关论文
共 50 条
  • [1] Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis
    Kumawat, Devesh
    Samanta, Ramanuj
    Sahay, Pranita
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 220 : 216 - 217
  • [2] Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis
    Fernandes Felix, Joao Paulo
    Cavalcanti Lira, Rodrigo Pessoa
    Grupenmacher, Alex Treiger
    Gomes de Assis Filho, Hermano Lucio
    Cosimo, Alexandre Brito
    Nascimento, Mauricio Abujamra
    Leite Arieta, Carlos Eduardo
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 213 : 195 - 202
  • [3] Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial
    Fernandes Felix, Joao Paulo
    Cavalcanti Lira, Rodrigo Pessoa
    Zacchia, Rafael Santos
    Toribio, Jaqueline Machado
    Nascimento, Mauricio Abujamra
    Leite Arieta, Carlos Eduardo
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (04) : 762 - 766
  • [4] Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: randomized controlled clinical trial (ISROT)
    Felix, Joao
    Zacchia, Rafael
    Toribio, Jaqueline
    Nascimento, Mauricio
    Arieta, Carlos
    Panetta, Heitor
    Balarin, Valdir
    Lira, Rodrigo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis
    Silveira, C
    Belfort, R
    Muccioli, C
    Holland, GN
    Victora, CG
    Horta, BL
    Nussenblatt, RB
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 134 (01) : 41 - 46
  • [6] Trimethoprim-Sulfamethoxazole Versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A Three-Year Follow-up
    Fernandes Felix, Joa Paulo
    Cavalcanti Lira, Rodrigo Pessoa
    Cosimo, Alexandre Brito
    Cardeal da Costa, Rodrigo Lourenco
    Nascimento, Mauricio Abujamra
    Leite Arieta, Carlos Eduardo
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 170 : 176 - 182
  • [7] The Effect of Long-term Intermittent Trimethoprim/Sulfamethoxazole Treatment on Recurrences of Toxoplasmic Retinochoroiditis: 10 Years of Follow-up
    Silveira, Claudio
    Muccioli, Cristina
    Nussenblatt, Robert
    Belfort, Rubens, Jr.
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2015, 23 (03) : 246 - 247
  • [8] LONG-TERM TREATMENT OF PERSISTENT OR RECURRENT URINARY-TRACT INFECTION WITH TRIMETHOPRIM-SULFAMETHOXAZOLE
    OGRADY, F
    FRY, IK
    MCSHERRY, A
    CATTELL, WR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 : S652 - S656
  • [9] LONG-TERM USE OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN CHILDREN WITH MENINGOMYELOCELES AND RECURRENT URINARY-TRACT INFECTIONS
    LIRENMAN, DS
    ARNOLD, WJD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1973, 128 : S636 - S639
  • [10] Long-term control of choroidal neovascularization in quiescent congenital toxoplasma retinochoroiditis with photodynamic therapy: 4-year results
    Neri P.
    Mercanti L.
    Mariotti C.
    Salvolini S.
    Giovannini A.
    [J]. International Ophthalmology, 2010, 30 (1) : 51 - 56